Evidence map›Paper›PMID 42249935›Full record

ArticleEuropean journal of applied physiology2026

Mechanisms of dyspnoea and exercise intolerance in smokers with preserved ratio impaired spirometry.

Alice Scussel, Nathalia Galvagni Rodrigues, Artur Zanelatto Santos, Laura Corrêa de Barros Trombin, Amanda Calage Pinto, Litiele Evelin Wagner, Marli Maria Knorst, James Dean, Dave Singh, Danilo Cortozi Berton

Abstract read
In one paragraph

Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alice ScusselPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.ORCID http://orcid.org/0009-0008-5729-8019
Nathalia Galvagni RodriguesPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
Artur Zanelatto SantosPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
Laura Corrêa de Barros TrombinPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
Amanda Calage PintoPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
Litiele Evelin WagnerPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
Marli Maria KnorstPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil.
James DeanMedicines Evaluation Unit, an IQVIA Business, Manchester, UK.
Dave SinghMedicines Evaluation Unit, an IQVIA Business, Manchester, UK.
Danilo Cortozi BertonPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul (UFRGS), Unidade de Fisiologia Pulmonar, Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Prédio A, Sala 2050, Porto Alegre, RS, Brazil. dberton@hcpa.edu.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSmokers with preserved ratio impaired spirometry (PRISm) present reduced forced expiratory volume in the first second (FEV₁ < 80% predicted) but preserved FEV

methodsIn this cross-sectional study, smokers (> 10 pack-years) from a specialized outpatient clinic were evaluated. Thirteen participants (11 females; 62.4 ± 7.7 years) with PRISm and 13 age- and sex-matched patients with mild-to-moderate COPD (FEV₁/FVC < 0.7; FEV₁ > 50% predicted) underwent incremental cardiopulmonary exercise testing on a cycle ergometer. Data from healthy nonsmoking controls were obtained from previous studies.

resultsPRISm and COPD groups had similarly reduced FEV₁ (~ 72% predicted) compared to controls (97% predicted), whereas FVC was lower in PRISm (73% predicted) than in COPD and controls (~ 95% predicted). Both patient groups showed higher ventilation, reduced ventilatory reserve, and greater dyspnoea at a given submaximal workload versus controls. Increased tidal volume/inspiratory capacity ratios were also observed, contributing to greater dyspnoea for a given ventilation and lower peak work rate (42 ± 16 vs. 68 ± 11 vs. 94 ± 17% predicted, respectively; all P < 0.05).

conclusionSmokers with PRISm exhibit increased dyspnoea and reduced exercise tolerance compared to healthy controls, largely driven by excessive ventilatory demand and reduced ventilatory capacity during submaximal exercise.

Indexed as

DyspneaExercise TolerancePulmonary Disease, Chronic ObstructiveSmokingAgedCross-Sectional StudiesExercise TestFemaleForced Expiratory VolumeHumansMaleMiddle AgedSmokersSpirometryVital CapacityCOPDDyspnoeaExercise testPreserved Ratio Impaired Spirometry (PRISm)SmokersSpirometry

Identifiers

PMID42249935
PMCPMC13451250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.